Holland–Frei Cancer Medicine.
Holland–Frei Cancer Medicine. - Tenth Edition - Department of Experimental Therapeutics The University of Texas MD Anderson Cancer Center Houston, Texas | John Wiley & Sons, Inc. 2023.
HOLLAND-FREI CANCER MEDICINE
The latest edition of the gold-standard in cancer science and clinical oncology references
In the newly revised Tenth Edition of Holland-Frei Cancer Medicine, a team of distinguished researchers and practitioners delivers a comprehensive and up-to-date discussion of cancer science and clinical oncology practice. The book contains timely and indispensable information on epidemiology, etiology, cancer biology, immunology, prevention, screening, clinical presentation, pathology, imaging, and therapy.
Grounded in a fundamental understanding of cancer biology, Holland-Frei Cancer Medicine combines scientific principles with clinical practice. It contains hundreds of full-color illustrations and photographs, tables, graphs, and algorithms that complement and enhance the complex topics discussed within the book. This book is an invaluable clinical tool that provides readers with overview boxes, additional references, and other pedagogic features designed to make the content easy to access and comprehend.
Readers will also find:
A translational and integrated approach throughout the book that combines cancer biology with cancer management A strong emphasis on multidisciplinary, research-driven patient care that improves outcomes and allows for the optimal use of all clinically appropriate therapies Discussions of the most current personalized cancer care, including molecular diagnostics and therapeutics
Perfect for medical oncologists, radiation oncologists, and internists, Holland-Frei Cancer Medicine, Tenth Edition will also earn a place in the libraries of allied health professionals involved in the treatment of cancer patients.
This book is published in collaboration with the American Association for Cancer Research: https://www.aacr.org/
9781119750703 1119750709 9781119750680 = abnormalities activation acute myeloid leukemia allele alterations AML amplification analysis Anderson Cancer Center APL apoptosis associated ATRA biomarkers BRAF breast cancer cancer cells Cancer Center Houston cancer genome Cancer Res cancer stem cells carcinoma cell death cellular Chapter chemotherapy chromatin chromosome Clin clinical trials clonal colorectal cancer CSC cytogenetic Deregulated detection differentiation disease DNA methylation domain drug EGFR encodes epigenetic exon Figure function fusion gene expression genome germline growth factor histone human cancer identified immune inhibition inhibitors lung cancer lymphoma malignant MD Anderson Cancer MD Professor mechanisms Medicine melanoma metastasis metastatic microRNAs miRNAs models molecular mutations Natl Acad Sci neoplasms normal oncogenes Oncol organoids pancreatic patients PhD phenotype Proc Natl Acad Professor Department protein RAS receptor regulation RNA role sarcoma sequencing solid tumors somatic studies subtypes syndrome Table target Texas MD Anderson therapeutic therapy thyroid tissue transcription factors translocation treatment tumor cells tumor suppressor genes University of Texas
--Medical / General, Medical / Internal Medicine, Medical / Oncology / General, Cancer -- Diagnosis -- Treatment, Cancer -- Treatment.